Skip to content
Open access

Tubular PFKFB3 drives diabetic kidney fibrosis via lactate-dependent H4K12 lactylation and HIPK2 transactivation

Jul 2026 · International Journal of Molecular Medicine · Vol 58, pp. 1-13 · 1 citation · 56 references
Medicine

TL;DR

It was demonstrated that the reduction in the levels of lactate levels markedly alleviated renal fibrosis in DKD and indicated that intervention approaches targeting PFKFB3-triggered HIPK2 activation in tubular cells may offer a novel therapeutic strategy for DKD.

Abstract

Aerobic glycolysis is increasingly recognized as a pathogenic driver in diabetic kidney disease (DKD). However, the epigenetic role of its end product, lactate, remains largely undefined. Spatial transcriptomics analysis revealed active glycolysis in tubular epithelial cells. The participation of histone lactylation in DKD was confirmed through inhibition of histone lactylation by glycolysis inhibitors or lactate in vivo. The potential target genes of H4K12 lactylation (H4K12la) were screened by CUT&Tag analyses. The candidate target genes were validated through ChIP-qPCR, RT-qPCR and western blot analyses. The present study found that the expression of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), a pivotal glycolytic regulator, was markedly upregulated in tubular epithelial cells derived from patients with DKD and from the corresponding mouse models. Inhibition of the expression of PFKFB3 mitigated the kidney fibrotic process and alleviated renal function in a DKD mouse model. Conversely, upregulation of PFKFB3 expression aggravated renal fibrogenesis and promoted the deterioration of renal pathology. Moreover, it was demonstrated that the reduction in the levels of lactate levels markedly alleviated renal fibrosis in DKD. With regard to its mechanism of action, lactate was generated via PFKFB3-driven glycolytic reprogramming and selectively enhanced H4K12 lactylation at the homeodomain-interacting protein kinase 2 (HIPK2) promoter, thereby activating its transcription and driving renal fibrotic progression. These findings indicated that PFKFB3 in renal tubules upregulates HIPK2 expression via facilitating H4K12la-dependent gene transcription. Therefore, intervention approaches targeting PFKFB3-triggered HIPK2 activation in tubular cells may offer a novel therapeutic strategy for DKD.

Read PDF

Similar papers

Open access Sep 2026

S100A1 Promotes MDM2‐Mediated KLF15 Ubiquitination to Regulate ID1‐Driven Tubular Injury in Diabetic Kidney Disease

Comparison of single‐cell RNA sequencing data of kidney samples from healthy controls and DKD patients reveals a novel S100A1‐MDM2‐KLF15‐ID1 regulatory axis in DKD pathogenesis and suggests targeting S100A1 might be a potential therapy for proximal tubular injury in DKD.

Zhi-Tao Zeng, Jia-Zhen Shang, Shou-Yu Chai et al. · 0 citations
Open access Sep 2026

Tubular NAT10 Promotes the Secretion of TGF-β and Lactate to Drive Fibroblast Activation in Diabetic Kidney Disease

In advanced diabetic kidney disease (DKD), tubulointerstitial fibrosis (TIF) is a key histopathological lesion accompanying progressive renal functional decline. However, the tubular mechanisms that drive tubulointerstitial fibrogenesis remain incompletely understood. N-acetyltransferase 10 (NAT10) mediates mRNA N4-ace...

Jin-Fang Lu, Yu-Qing Feng, Xu-Jun Peng et al. · 0 citations
Open access Oct 2026

ITGB2 promotes HIF-1α/GLUT1 mediated glucose metabolic reprogramming in renal tubular epithelial cells to aggravate the progression of diabetic kidney disease

Diabetic kidney disease (DKD) is characterized by tubular metabolic remodeling, inflammation, and profibrotic injury. However, whether integrin β2 (ITGB2) links high-glucose (HG) stress to hypoxia-inducible factor-1α (HIF-1α)/glucose transporter 1 (GLUT1)-dependent metabolic reprogramming in renal tubular epithelial ce...

Jun Peng, Qiao-Meng Yuan, Lu Zhou et al. · 0 citations
Open access Aug 2026

FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy.

FOXO4 promotes HG-induced HK-2 cell damage and inflammation via regulating TFPI2 in vitro and alleviates renal injury and inflammation in vivo, and TFPI2 knockdown alone alleviates renal injury and inflammation in vivo.

Liqin Mu, Yu Zhao, Yang Li et al. · 0 citations
Sep 2026

SGK2 Promotes NEDD4L-Mediated ACSL4 Ubiquitination to Inhibit Ferroptosis and Alleviate Diabetic Kidney Disease.

It is found that SGK2 suppresses tubular ferroptosis in DKD through NEDD4L-dependent K48-linked ubiquitination and proteasomal degradation of ACSL4, thereby limiting lipid peroxidation and protecting the renal tubules.

Fei Zhang, An-Dong Zhang, Li-Wen Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.